-0.01 | -0.08%
| Price and Volume | |
|---|---|
| Recent Price | 11.80 |
| 52 Week High | 16.00 |
| 52 Week Low | 6.94 |
| Avg. Daily Vol. (Mil) | 2.18 |
| Beta (3 year) | 2.30 |
| Share Related Items | |
| Mkt Cap (Mil) | 702.36 |
| Shares Out (Mil) | 59.52 |
| Float (Mil) | 49.28 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.90 |
| Current Ratio | 3.20 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 9.00 |
| Price/Sales | 3.36 |
| Price/Book | 2.93 |
| Price/Cash Flow | 9.20 |
| Per Share Data | |
| Earnings | 1.31 |
| Sales | 3.52 |
| Book Value | 4.02 |
| Cash Flow | 1.28 |
| Business Summary | |
|---|---|
| Spectrum Pharmaceuticals Inc. is a biotechnology company with fully integrated commercial and drug development operations. | |
| General Information | |
| 11500 South Eastern Avenue
Suite 240 Henderson, NV 89052 |
|
| www.neotherapeutics.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 176 | |
| CEO: Dr. Rajesh C. Shrotriya, | |
| Short Interest | |
| Current Month (Mil) | 24.16 |
| Previous Month (Mil) | 21.37 |
| Short Interest Ratio (Days) | 9.10 |
| Management Effectiveness | |
| Return on Equity | 34.40 |
| Return on Assets | 24.60 |
| Return on Investments | 34.30 |
| Profitability | |
| Gross Margin | 78.10 |
| EBIT Margin | 30.00 |
| Profit Margin | 39.30 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.05
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet